LEADER 02832nam 2200637 450 001 9910797562403321 005 20230807193057.0 010 $a0-19-029707-7 010 $a0-19-025173-5 010 $a0-19-939085-1 035 $a(CKB)3710000000470940 035 $a(EBL)4083508 035 $a(SSID)ssj0001544032 035 $a(PQKBManifestationID)16134614 035 $a(PQKBTitleCode)TC0001544032 035 $a(PQKBWorkID)14792293 035 $a(PQKB)11083391 035 $a(MiAaPQ)EBC4083508 035 $a(StDuBDS)EDZ0001291892 035 $a(Au-PeEL)EBL4083508 035 $a(CaPaEBR)ebr11118570 035 $a(CaONFJC)MIL828514 035 $a(OCoLC)936291915 035 $a(EXLCZ)993710000000470940 100 $a20150326h20152015 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBreast cancer $efundamentals of evidence-based disease management /$fI. Craig Henderson 210 1$aOxford ;$aNew York :$cOxford University Press,$d[2015] 210 4$dİ2015 215 $a1 online resource (257 p.) 300 $aDescription based upon print version of record. 311 $a0-19-991998-4 320 $aIncludes bibliographical references and index. 327 $aEpidemiology and risk factors for breast cancer -- Primary and secondary prevention of breast cancer -- Premalignant changes and in situ carcinoma -- Natural history of invasive breast cancer -- Histology of breast cancer -- Clinical and pathological staging -- Molecular factors as prognostic/predictive tools and therapeutic targets -- Diagnosis, work-up, and follow-up of breast cancer patients -- Treatment of the breast and regional lymph nodes surgery and radiation therapy -- Adjuvant systemic therapy -- Neoadjuvant therapy and locally-advanced or inflammatory breast cancer -- Management of metastatic disease. 330 8 $aThis volume provides an in-depth understanding of the biology of breast cancer, the natural history of the disease, the use of molecular markers, the interpretation of clinical trial data, and the integration of multiple therapeutic modalities. Outcomes of clinical trials and details about commonly used drug regimens, drug dosage, and the expected side effects are summarised. 606 $aBreast$xPathophysiology 606 $aCombined modality therapy 606 $aCancer invasiveness 606 $aMetastasis 615 0$aBreast$xPathophysiology. 615 0$aCombined modality therapy. 615 0$aCancer invasiveness. 615 0$aMetastasis. 676 $a616.99/449 700 $aHenderson$b I. Craig$01526711 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797562403321 996 $aBreast cancer$93769330 997 $aUNINA